PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
31.46
-0.07 (-0.22%)
At close: Dec 31, 2025, 4:00 PM EST
32.70
+1.24 (3.94%)
After-hours: Dec 31, 2025, 7:47 PM EST
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 8 analysts that cover PROCEPT BioRobotics stock have a consensus rating of "Buy" and an average price target of $51.13, which forecasts a 62.52% increase in the stock price over the next year. The lowest target is $38 and the highest is $62.
Price Target: $51.13 (+62.52%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PROCEPT BioRobotics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 3 | 3 | 3 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 8 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $50 → $47 | Strong Buy | Maintains | $50 → $47 | +49.40% | Dec 18, 2025 |
| UBS | UBS | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | +97.08% | Dec 12, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $55 → $38 | Strong Buy → Hold | Downgrades | $55 → $38 | +20.79% | Dec 8, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $56 → $51 | Buy | Maintains | $56 → $51 | +62.11% | Dec 2, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $85 → $50 | Strong Buy | Maintains | $85 → $50 | +58.93% | Nov 5, 2025 |
Financial Forecast
Revenue This Year
332.93M
from 224.50M
Increased by 48.30%
Revenue Next Year
430.96M
from 332.93M
Increased by 29.44%
EPS This Year
-1.54
from -1.75
EPS Next Year
-1.16
from -1.54
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 355.4M | 454.7M | ||||
| Avg | 332.9M | 431.0M | ||||
| Low | 318.0M | 406.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 58.3% | 36.6% | ||||
| Avg | 48.3% | 29.4% | ||||
| Low | 41.6% | 22.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.54 | -0.55 | ||||
| Avg | -1.54 | -1.16 | ||||
| Low | -1.51 | -1.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.